| Year |
Citation |
Score |
| 2020 |
Shi H, Koronyo Y, Rentsendorj A, Regis GC, Sheyn J, Fuchs DT, Kramerov AA, Ljubimov AV, Dumitrascu OM, Rodriguez AR, Barron E, Hinton DR, Black KL, Miller CA, Mirzaei N, et al. Identification of early pericyte loss and vascular amyloidosis in Alzheimer's disease retina. Acta Neuropathologica. PMID 32043162 DOI: 10.1007/S00401-020-02134-W |
0.386 |
|
| 2019 |
Bilousova T, Melnik M, Miyoshi E, Gonzalez BL, Poon WW, Vinters HV, Miller CA, Corrada MM, Kawas C, Hatami A, Albay R, Glabe C, Gylys KH. Apolipoprotein E/Aβ Complex Accumulates in AD Cortical Synapses via apoE Receptors and Is Enhanced by APOE4. The American Journal of Pathology. PMID 31108099 DOI: 10.1016/J.Ajpath.2019.04.010 |
0.394 |
|
| 2019 |
Rentsendorj A, Koronyo Y, Fuchs D, Sheyn J, Regis GC, Mirzaei N, Barron E, Black KL, Hinton DR, Miller CA, Koronyo-Hamaoui M. P2-193: Early Retinal Amyloid-Associated Pathological Changes In Mci And Ad Patients Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.2600 |
0.39 |
|
| 2019 |
Shi H, Koronyo Y, Sheyn J, Fuchs D, Black KL, Miller CA, Koronyo-Hamaoui M. Retinal Vascular Amyloidosis Along With Pericyte Loss In Mci And Ad Patients Alzheimers & Dementia. 15: 239. DOI: 10.1016/J.Jalz.2019.06.047 |
0.335 |
|
| 2018 |
Maya K, Rentsendorj A, Barron E, Fuchs D, Miller CA, Black KL, Hinton DR, Meli G, Koronyo Y. P4-254: IDENTIFICATION OF INFLAMMATORY PROCESSES SURROUNDING AMYLOID-β DEPOSITS IN THE RETINA OF MCI AND AD PATIENTS Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.07.076 |
0.346 |
|
| 2017 |
Koronyo Y, Biggs D, Barron E, Boyer DS, Pearlman JA, Au WJ, Kile SJ, Blanco A, Fuchs DT, Ashfaq A, Frautschy S, Cole GM, Miller CA, Hinton DR, Verdooner SR, et al. Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease. Jci Insight. 2. PMID 28814675 DOI: 10.1172/Jci.Insight.93621 |
0.413 |
|
| 2017 |
Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC, Martin ER, Grenier-Boley B, Heilmann-Heimbach S, Chouraki V, Kuzma AB, ... ... Miller CA, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nature Genetics. PMID 28714976 DOI: 10.1038/Ng.3916 |
0.323 |
|
| 2016 |
Bilousova T, Miller CA, Poon WW, Vinters HV, Corrada M, Kawas C, Hayden EY, Teplow DB, Glabe C, Albay R, Cole GM, Teng E, Gylys KH. Synaptic Amyloid-β Oligomers Precede p-Tau and Differentiate High Pathology Control Cases. The American Journal of Pathology. 186: 185-98. PMID 26718979 DOI: 10.1016/J.Ajpath.2015.09.018 |
0.43 |
|
| 2015 |
Zhao Z, Sagare AP, Ma Q, Halliday MR, Kong P, Kisler K, Winkler EA, Ramanathan A, Kanekiyo T, Bu G, Owens NC, Rege SV, Si G, Ahuja A, Zhu D, ... Miller CA, et al. Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance. Nature Neuroscience. 18: 978-87. PMID 26005850 DOI: 10.1038/Nn.4025 |
0.349 |
|
| 2015 |
Halliday MR, Rege SV, Ma Q, Zhao Z, Miller CA, Winkler EA, Zlokovic BV. Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 25757756 DOI: 10.1038/Jcbfm.2015.44 |
0.406 |
|
| 2015 |
Wang LS, Naj AC, Graham RR, Crane PK, Kunkle BW, Cruchaga C, Murcia JD, Cannon-Albright L, Baldwin CT, Zetterberg H, Blennow K, Kukull WA, Faber KM, Schupf N, Norton MC, ... ... Miller CA, et al. Rarity of the Alzheimer disease-protective APP A673T variant in the United States. Jama Neurology. 72: 209-16. PMID 25531812 DOI: 10.1001/Jamaneurol.2014.2157 |
0.388 |
|
| 2015 |
Sokolow S, Henkins KM, Bilousova T, Gonzalez B, Vinters HV, Miller CA, Cornwell L, Poon WW, Gylys KH. Pre-synaptic C-terminal truncated tau is released from cortical synapses in Alzheimer's disease. Journal of Neurochemistry. 133: 368-79. PMID 25393609 DOI: 10.1111/Jnc.12991 |
0.394 |
|
| 2015 |
Gylys KH, Bilousova T, Teng E, Vinters HV, Miller CA, Poon WW, Apostolova LG, Frautschy SA, John V, Bredesen DE, Cole GM. O2-06-03: Release of c-terminal truncated and intact tau from Alzheimer's disease cortical synapses Alzheimer's & Dementia. 11: P186-P187. DOI: 10.1016/J.Jalz.2015.07.161 |
0.335 |
|
| 2014 |
Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YS, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, Wang LS, Kauwe JS, Huentelman MJ, Myers AJ, Bird TD, Boeve BF, ... ... Miller CA, et al. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. Jama Neurology. 71: 1394-404. PMID 25199842 DOI: 10.1001/Jamaneurol.2014.1491 |
0.313 |
|
| 2014 |
Koronyo Y, Biggs D, Barron E, Hinton DR, Boyer DS, Fuchs DS, Miller CA, Frautschy SA, Cole GM, Verdooner SR, Black KL, Koronyo-Hamaoui M. P3-107: RETINAL IMAGING OF AB DEPOSITS IN AD PATIENTS: FROM HISTOLOGICAL EXAMINATION TO CLINICAL TRIALS Alzheimer's & Dementia. 10: P667-P667. DOI: 10.1016/J.Jalz.2014.05.1196 |
0.328 |
|
| 2013 |
Tai LM, Bilousova T, Jungbauer L, Roeske SK, Youmans KL, Yu C, Poon WW, Cornwell LB, Miller CA, Vinters HV, Van Eldik LJ, Fardo DW, Estus S, Bu G, Gylys KH, et al. Levels of soluble apolipoprotein E/amyloid-β (Aβ) complex are reduced and oligomeric Aβ increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples. The Journal of Biological Chemistry. 288: 5914-26. PMID 23293020 DOI: 10.1074/Jbc.M112.442103 |
0.393 |
|
| 2013 |
Koronyo Y, Fuchs D(, Sheyn J, Miller C, Black K, Koronyo-Hamaoui M. Local inflammatory response associated with beta-amyloid deposition in the retina of Alzheimer's disease and MCI patients Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.441 |
0.35 |
|
| 2012 |
Mo Y, Williams C, Miller CA. DENN/MADD/IG20 alternative splicing changes and cell death in Alzheimer's disease. Journal of Molecular Neuroscience : Mn. 48: 97-110. PMID 22678883 DOI: 10.1007/S12031-012-9782-9 |
0.37 |
|
| 2012 |
Henkins KM, Sokolow S, Miller CA, Vinters HV, Poon WW, Cornwell LB, Saing T, Gylys KH. Extensive p-tau pathology and SDS-stable p-tau oligomers in Alzheimer's cortical synapses. Brain Pathology (Zurich, Switzerland). 22: 826-33. PMID 22486774 DOI: 10.1111/J.1750-3639.2012.00598.X |
0.413 |
|
| 2012 |
Arold S, Sullivan P, Bilousova T, Teng E, Miller CA, Poon WW, Vinters HV, Cornwell LB, Saing T, Cole GM, Gylys KH. Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex. Acta Neuropathologica. 123: 39-52. PMID 22020632 DOI: 10.1007/S00401-011-0892-1 |
0.38 |
|
| 2012 |
Sokolow S, Luu SH, Nandy K, Miller CA, Vinters HV, Poon WW, Gylys KH. Preferential accumulation of amyloid-beta in presynaptic glutamatergic terminals (VGluT1 and VGluT2) in Alzheimer's disease cortex. Neurobiology of Disease. 45: 381-7. PMID 21914482 DOI: 10.1016/J.Nbd.2011.08.027 |
0.401 |
|
| 2012 |
Sokolow S, Henkins KM, Bilousova T, Miller CA, Vinters HV, Poon W, Cole GM, Gylys KH. AD synapses contain abundant Aβ monomer and multiple soluble oligomers, including a 56-kDa assembly. Neurobiology of Aging. 33: 1545-55. PMID 21741125 DOI: 10.1016/J.Neurobiolaging.2011.05.011 |
0.39 |
|
| 2012 |
Koronyo Y, Salumbides B, Sheyn J, Fuchs S, Cohen R, Miller C, Black K, Koronyo-Hamaoui M. The retina as a window to monitor Alzheimer's disease in human and rodent models: In vivo imaging of retinal Aβ plaques for immunotherapy assessment Alzheimers & Dementia. 8: 351. DOI: 10.1016/J.Jalz.2012.05.963 |
0.348 |
|
| 2011 |
Sokolow S, Luu SH, Headley AJ, Hanson AY, Kim T, Miller CA, Vinters HV, Gylys KH. High levels of synaptosomal Na(+)-Ca(2+) exchangers (NCX1, NCX2, NCX3) co-localized with amyloid-beta in human cerebral cortex affected by Alzheimer's disease. Cell Calcium. 49: 208-16. PMID 21382638 DOI: 10.1016/J.Ceca.2010.12.008 |
0.388 |
|
| 2011 |
Koronyo-Hamaoui M, Koronyo Y, Ljubimov AV, Miller CA, Ko MK, Black KL, Schwartz M, Farkas DL. Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage. 54: S204-17. PMID 20550967 DOI: 10.1016/J.Neuroimage.2010.06.020 |
0.399 |
|
| 2010 |
Chow TW, Varpetian A, Moss T, Vinters HV, Marquez S, Miller C. Alzheimer's disease neuropathologic changes in semantic dementia. Neurocase. 16: 15-22. PMID 19866390 DOI: 10.1080/13554790903193174 |
0.709 |
|
| 2010 |
Henkins KM, Arold S, Sokolow S, Miller C, Vinters H, Cole G, Gylys K. P4-147: Tau Pathology in AD Cortical Synapses: Evidence for Fragmentation and Aggregation Alzheimer's & Dementia. 6: e67-e67. DOI: 10.1016/J.Jalz.2010.08.206 |
0.38 |
|
| 2010 |
Sokolow S, Luu SH, Vinters HV, Miller CA, Gylys KH. P1-240: Glutamatergic (VGLUT1) synapses are not lost in Alzheimer's disease cerebral cortex, but preferentially accumulate amyloid-beta and p-tau pathology Alzheimer's & Dementia. 6: S243-S243. DOI: 10.1016/J.Jalz.2010.05.791 |
0.367 |
|
| 2010 |
Gylys KH, Arold SP, Henkins KM, Poon W, Miller CA, Vinters HV, Cole GM. O4-02-01: Apoliprotein-E is increased in Alzheimer's disease synapses and associates with amyloid beta Alzheimer's & Dementia. 6: S152-S152. DOI: 10.1016/J.Jalz.2010.05.473 |
0.332 |
|
| 2010 |
Koronyo Y, Koronyo-Hamaoui M, Ljubimov AV, Miller CA, Ko MK, Black KL, Schwartz M, Farkas DL. Noninvasive optical imaging of retinal amyloid plaques in mice model of Alzheimer's disease: Early detection and treatment assessment Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.1686 |
0.332 |
|
| 2009 |
Williams C, Mehrian Shai R, Wu Y, Hsu YH, Sitzer T, Spann B, McCleary C, Mo Y, Miller CA. Transcriptome analysis of synaptoneurosomes identifies neuroplasticity genes overexpressed in incipient Alzheimer's disease. Plos One. 4: e4936. PMID 19295912 DOI: 10.1371/Journal.Pone.0004936 |
0.333 |
|
| 2008 |
Fein JA, Sokolow S, Miller CA, Vinters HV, Yang F, Cole GM, Gylys KH. Co-localization of amyloid beta and tau pathology in Alzheimer's disease synaptosomes. The American Journal of Pathology. 172: 1683-92. PMID 18467692 DOI: 10.2353/Ajpath.2008.070829 |
0.373 |
|
| 2007 |
Gylys KH, Fein JA, Yang F, Miller CA, Cole GM. Increased cholesterol in Abeta-positive nerve terminals from Alzheimer's disease cortex. Neurobiology of Aging. 28: 8-17. PMID 16332401 DOI: 10.1016/J.Neurobiolaging.2005.10.018 |
0.402 |
|
| 2006 |
Williams C, Shai RM, Wu Y, Miller CA. P3-441: Expression of mRNAs regulating local translation in synaptic terminals of MCI and early ad brain Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.1712 |
0.331 |
|
| 2005 |
Roberson ED, Hesse JH, Rose KD, Slama H, Johnson JK, Yaffe K, Forman MS, Miller CA, Trojanowski JQ, Kramer JH, Miller BL. Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology. 65: 719-25. PMID 16157905 DOI: 10.1212/01.Wnl.0000173837.82820.9F |
0.385 |
|
| 2005 |
Ghanevati M, Miller CA. Phospho-beta-catenin accumulation in Alzheimer's disease and in aggresomes attributable to proteasome dysfunction. Journal of Molecular Neuroscience : Mn. 25: 79-94. PMID 15781969 DOI: 10.1385/Jmn:25:1:079 |
0.34 |
|
| 2004 |
Gylys KH, Fein JA, Yang F, Wiley DJ, Miller CA, Cole GM. Synaptic changes in Alzheimer's disease: increased amyloid-beta and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescence. The American Journal of Pathology. 165: 1809-17. PMID 15509549 DOI: 10.1016/S0002-9440(10)63436-0 |
0.387 |
|
| 2004 |
Mok W, Chow TW, Zheng L, Mack WJ, Miller C. Clinicopathological concordance of dementia diagnoses by community versus tertiary care clinicians American Journal of Alzheimer's Disease and Other Dementias. 19: 161-165. PMID 15214202 DOI: 10.1177/153331750401900309 |
0.396 |
|
| 2004 |
Del Villar K, Miller CA. Down-regulation of DENN/MADD, a TNF receptor binding protein, correlates with neuronal cell death in Alzheimer's disease brain and hippocampal neurons. Proceedings of the National Academy of Sciences of the United States of America. 101: 4210-5. PMID 15007167 DOI: 10.1073/Pnas.0307349101 |
0.38 |
|
| 2003 |
Kubo T, Kumagae Y, Miller CA, Kaneko I. Beta-amyloid racemized at the Ser26 residue in the brains of patients with Alzheimer disease: implications in the pathogenesis of Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 62: 248-59. PMID 12638729 DOI: 10.1093/Jnen/62.3.248 |
0.388 |
|
| 2003 |
Villar KD, Miller CA. Oxidative stress and death domain proteins in Alzheimer's disease Clinical Neuroscience Research. 2: 316-323. DOI: 10.1016/S1566-2772(03)00008-2 |
0.333 |
|
| 2002 |
Giri R, Selvaraj S, Miller CA, Hofman F, Yan SD, Stern D, Zlokovic BV, Kalra VK. Effect of endothelial cell polarity on beta-amyloid-induced migration of monocytes across normal and AD endothelium. American Journal of Physiology. Cell Physiology. 283: C895-904. PMID 12176746 DOI: 10.1152/Ajpcell.00293.2001 |
0.377 |
|
| 2002 |
Bading JR, Yamada S, Mackic JB, Kirkman L, Miller C, Calero M, Ghiso J, Frangione B, Zlokovic BV. Brain clearance of Alzheimer's amyloid-beta40 in the squirrel monkey: a SPECT study in a primate model of cerebral amyloid angiopathy. Journal of Drug Targeting. 10: 359-68. PMID 12164385 DOI: 10.1080/10611860290031831 |
0.314 |
|
| 2002 |
Rosen HJ, Hartikainen KM, Jagust W, Kramer JH, Reed BR, Cummings JL, Boone K, Ellis W, Miller C, Miller BL. Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD. Neurology. 58: 1608-15. PMID 12058087 DOI: 10.1212/Wnl.58.11.1608 |
0.361 |
|
| 2000 |
Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, Holtzman DM, Miller CA, Strickland DK, Ghiso J, Zlokovic BV. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. The Journal of Clinical Investigation. 106: 1489-99. PMID 11120756 DOI: 10.1172/Jci10498 |
0.308 |
|
| 1999 |
Bretsky PM, Buckwalter JG, Seeman TE, Miller CA, Poirier J, Schellenberg GD, Finch CE, Henderson VW. Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease. Alzheimer Disease and Associated Disorders. 13: 216-21. PMID 10609670 DOI: 10.1097/00002093-199910000-00007 |
0.366 |
|
| 1999 |
Kumagae Y, Zhang Y, Kim O, Miller CA. Human c-Jun N-terminal kinase expression and activation in the nervous system. Molecular Brain Research. 67: 10-17. PMID 10101227 DOI: 10.1016/S0169-328X(99)00013-3 |
0.305 |
|
| 1998 |
Zhou L, Miller BL, McDaniel CH, Kelly L, Kim OJ, Miller CA. Frontotemporal dementia: neuropil spheroids and presynaptic terminal degeneration. Annals of Neurology. 44: 99-109. PMID 9667597 DOI: 10.1002/Ana.410440116 |
0.392 |
|
| 1997 |
Zhou L, Kelly L, Kim OJ, Miller B, Miller CA. Fronto-Temporal Dementia And Parkinsonism: Tauopathy With Neuropil Spheroids Journal of Neuropathology and Experimental Neurology. 56: 611. DOI: 10.1097/00005072-199705000-00175 |
0.32 |
|
| 1996 |
Sinha UK, Saadat D, Linthicum FH, Hollen KM, Miller CA. Temporal bone findings in Alzheimer's disease. The Laryngoscope. 106: 1-5. PMID 8544613 DOI: 10.1097/00005537-199601000-00001 |
0.392 |
|
| 1995 |
Mohit AA, Martin JH, Miller CA. p493F12 kinase: a novel MAP kinase expressed in a subset of neurons in the human nervous system. Neuron. 14: 67-78. PMID 7826642 DOI: 10.1016/0896-6273(95)90241-4 |
0.351 |
|
| 1995 |
Smith MA, Rudnicka-Nawrot M, Richey PL, Praprotnik D, Mulvihill P, Miller CA, Sayre LM, Perry G. Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. Journal of Neurochemistry. 64: 2660-6. PMID 7539057 DOI: 10.1046/J.1471-4159.1995.64062660.X |
0.412 |
|
| 1994 |
Waters CH, Miller CA. Autosomal dominant Lewy body parkinsonism in a four-generation family. Annals of Neurology. 35: 59-64. PMID 8285594 DOI: 10.1002/Ana.410350110 |
0.304 |
|
| 1993 |
Sinha UK, Hollen KM, Rodriguez R, Miller CA. Auditory system degeneration in Alzheimer's disease. Neurology. 43: 779-85. PMID 8469340 DOI: 10.1212/Wnl.43.4.779 |
0.364 |
|
| 1993 |
Sinha UK, Hollen KM, Miller CA. Abnormal neuritic architecture identified by Di-I in Pick's disease. Journal of Neuropathology and Experimental Neurology. 52: 411-8. PMID 8355029 DOI: 10.1097/00005072-199307000-00008 |
0.34 |
|
| 1993 |
Richey PL, Smith MA, Miller CA, Nawrot M, Perry G. ALDEHYDE-MODIFICATION OF THE NEUROFILAMENT COMPONENT OF NEUROFIBRILLARY TANGLES IN ALZHEIMER DISEASE Journal of Neuropathology and Experimental Neurology. 52: 304. DOI: 10.1097/00005072-199305000-00174 |
0.369 |
|
| 1991 |
Samuel WA, Henderson VW, Miller CA. Severity of dementia in Alzheimer disease and neurofibrillary tangles in multiple brain regions. Alzheimer Disease and Associated Disorders. 5: 1-11. PMID 2025419 DOI: 10.1097/00002093-199100510-00001 |
0.333 |
|
| 1991 |
Adams JD, Klaidman LK, Odunze IN, Shen HC, Miller CA. Alzheimer's and Parkinson's disease - Brain levels of glutathione, glutathione disulfide, and vitamin E Molecular and Chemical Neuropathology. 14: 213-226. PMID 1958264 DOI: 10.1007/Bf03159937 |
0.344 |
|
| 1989 |
Blanks JC, Hinton DR, Sadun AA, Miller CA. Retinal ganglion cell degeneration in Alzheimer's disease. Brain Research. 501: 364-72. PMID 2819446 DOI: 10.1016/0006-8993(89)90653-7 |
0.413 |
|
| 1989 |
Mohit A, Rudnlcka M, Atkinson R, Garner J, Miller C. PARTIAL MOLECULAR CHARACTERIZATION OF A NEURONAL ANTIGEN IN AD-VULNERABLE NEURONS Journal of Neuropathology and Experimental Neurology. 48: 341. DOI: 10.1097/00005072-198905000-00126 |
0.317 |
|
| 1987 |
Miller CA, Rudnicka M, Hinton DR, Blanks JC, Kozlowski M. Monoclonal antibody identification of subpopulations of cerebral cortical neurons affected in Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America. 84: 8657-61. PMID 3120196 DOI: 10.1073/Pnas.84.23.8657 |
0.361 |
|
| 1986 |
Hinton DR, Sadun AA, Blanks JC, Miller CA. Optic-nerve degeneration in Alzheimer's disease. The New England Journal of Medicine. 315: 485-7. PMID 3736630 DOI: 10.1056/Nejm198608213150804 |
0.384 |
|
| Show low-probability matches. |